UK Telemedicine Market is Expected to Reach around GBP 410 Million by 2022: Ken Research

• The increase in number of aging population will therefore increase the demand of telemedicine in UK.
• The increasing acceptance of 4G and 5G spectrum and growing acceptance of telemedicine in UK will pose as an opportunity for the players in the telemedicine market.
• Increasing prevalence of chronic diseases and continual investments from both public and private sectors will thereby increase the demand of telemedicine in UK.

The increasing acceptance of 4G and 5G spectrum and growing acceptance of telemedicine in UK is posing as opportunities for the players in the telemedicine market. Babylon Health will be able to develop its artificial intelligence technology to a great level and will be able to diagnose and foresee personal health issues better than doctors. The demand for telemedicine in UK is expected to grow at a rapid pace from the year 2021 to 2022. The growth will be driven by the increasing emphasis of healthcare information technology (HIT) players, increasing prevalence of chronic diseases and continual investments from both public and private sectors.

UK government has implemented data protection act 2018. This act will secure the patient data in hospitals and with telemedicine companies. The hospitals and telemedicine providers must make sure that the patient information is used fairly, lawfully and transparently for specific and explicit purposes.

Analysts at Ken Research in their latest publication “UK Telemedicine Market Outlook To 2022 - by Services (Tele Home & M-Health and Tele Hospital), by Technology Platform (Software, Hardware and Telecom), by Clinical Applications (Tele Cancer Services, Tele Radiology, Tele Pathology, Tele Neurology, Tele Psychology and Others)” believe that promoting better regulations, providing access to patient’s long term medical records, partnering with UK offices will aid the telemedicine market. In 2017, Tele cancer services have dominated the market in terms of domestic revenue. Tele cancer services dominate because of the rising number of cancer cases in the country. In 2017, the Tele Radiology contributed the second highest share followed by Tele Pathology, Tele Neurology, Tele Psychology services. Others services include dermatology, epidemiology, prescription counseling, surgical applications, cardiology and dentistry has contributed the least share in UK Telemedicine market in 2017.

UK Telemedicine market is expected to register positive CAGR of around 10.4% during the period 2018-2022 in terms of revenue. Providing better data security and adopting different marketing techniques to create awareness is expected to have positive impact on the overall telemedicine market.

For More Information, Refer to the Link below:
https://www.kenresearch.com/healthcare/general-healthcare/uk-telemedicine-market/152428-91.html

Products Covered:
Telemedicine Services (Tele Home & M-Health and Tele Hospital), by Technology Platform (Software, Hardware and Telecom), by Telemedicine Clinical Applications (Tele Cancer Services, Tele Radiology, Tele Pathology, Tele Neurology, Tele Psychology and Others)

Companies Covered:
Immedicare, Babylon Health, Push Doctor, Tele Medicine Clinic, Doctor Care Anywhere, Toothpick, Home Touch, Zesty, Skin Analytics, Capture Proof and Medio.Link

Related Reports:
https://www.kenresearch.com/healthcare/general-healthcare/global-telemedicine-market-forecast/142618-91.html

https://www.kenresearch.ae/healthcare/general-healthcare/us-telemedicine-market-research-report/531-91.html

https://www.kenresearch.com/healthcare/general-healthcare/africa-ehealth-market-research-report/77813-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. We provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies.

This release was published on openPR.